XML 38 R28.htm IDEA: XBRL DOCUMENT v3.6.0.2
Business, Basis of Presentation and Business Combinations (Details Textual)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Apr. 28, 2016
USD ($)
$ / shares
shares
Oct. 31, 2015
USD ($)
May 31, 2015
USD ($)
Dec. 31, 2016
USD ($)
Dec. 31, 2015
USD ($)
Dec. 31, 2016
USD ($)
Dec. 31, 2015
USD ($)
Jun. 30, 2016
USD ($)
Apr. 28, 2016
CAD
CAD / shares
Oct. 05, 2015
USD ($)
May 20, 2015
USD ($)
Business Acquisition [Line Items]                      
Stockholders' Equity, Reverse Stock Split           On June 8, 2015, we reincorporated as a domestic Delaware corporation under Delaware General Corporate Law and changed our name from Rosewind Corporation to Aytu BioScience, Inc., and effected a reverse stock split in which each common stockholder received one share of common stock for every 12.174 shares outstanding. On June 30, 2016, Aytu effected another reverse stock split in which each common stockholder received one share of common stock for every 12 shares outstanding (herein referred to collectively as the Reverse Stock Splits). All share and per share amounts in this report have been adjusted to reflect the effect of these Reverse Stock Splits.          
Amortization of Intangible Assets       $ 437,014 $ 108,489 $ 874,029 $ 165,936        
Developed Technology Rights [Member]                      
Business Acquisition [Line Items]                      
Amortization of Intangible Assets           520,000          
Trade Names [Member]                      
Business Acquisition [Line Items]                      
Amortization of Intangible Assets           810,000          
Customer Contracts [Member]                      
Business Acquisition [Line Items]                      
Amortization of Intangible Assets           140,000          
Prostascint Business [Member]                      
Business Acquisition [Line Items]                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Total     $ 2,400,000               $ 2,391,000
Payments to Acquire Businesses, Gross     1,000,000                
Business Combination, Consideration Transferred, Liabilities Incurred     227,000                
Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High     $ 2,500,000                
Business Combination Contingent Consideration Percentage     8.00%                
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset     $ 664,000     730,000          
Amortization of Intangible Assets       40,000 40,000 80,000 80,000        
Business Combination Consideration Transferred Product Inventory     $ 500,000                
Jazz Pharmaceuticals Inc [Member] | Prosta Scint [Member] | Developed Technology Rights [Member]                      
Business Acquisition [Line Items]                      
Finite-Lived Intangible Assets, Gross       790,000   790,000          
Jazz Pharmaceuticals Inc [Member] | Prosta Scint [Member] | Trade Names [Member]                      
Business Acquisition [Line Items]                      
Finite-Lived Intangible Assets, Gross       80,000   80,000          
Jazz Pharmaceuticals Inc [Member] | Prosta Scint [Member] | Customer Contracts [Member]                      
Business Acquisition [Line Items]                      
Finite-Lived Intangible Assets, Gross       720,000   720,000          
Primsol Business [Member]                      
Business Acquisition [Line Items]                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Total                   $ 1,799,000  
Payments to Acquire Businesses, Gross   $ 500,000                  
Business Combination, Consideration Transferred, Liabilities Incurred   142,000                  
Amortization of Intangible Assets       61,000 $ 51,000 122,000 $ 51,000        
Business Combination Consideration Transferred Inventory   102,000       102,000          
Business Combination Consideration Transferred Product Inventory   40,000                  
Business Combination Consideration Transferred Work In Process Inventory           80,000          
Primsol Business [Member] | Paid on April 1, 2016 [Member]                      
Business Acquisition [Line Items]                      
Business Combination, Consideration Transferred, Liabilities Incurred   500,000                  
Primsol Business [Member] | No Later Than July 01, 2016 [Member]                      
Business Acquisition [Line Items]                      
Business Combination, Consideration Transferred, Liabilities Incurred   500,000                  
Primsol Business [Member] | No Later Than November 30, 2016 [Member]                      
Business Acquisition [Line Items]                      
Business Combination, Consideration Transferred, Liabilities Incurred   $ 250,000                  
Natesto [Member]                      
Business Acquisition [Line Items]                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Total       10,500,000   10,500,000          
Payments to Acquire Businesses, Gross $ 2,000,000                    
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset           3,300,000   $ 3,200,000      
Amortization of Intangible Assets       330,000   659,000          
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares | shares 12,245,411                    
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned | CAD                 CAD 2,534,800    
Business Acquisition, Share Price | (per share) $ 0.16               CAD 0.207    
One Time Non-Refundable Payments $ 37,500,000                    
Other Accrued Liabilities       620,000   620,000          
Accretion Expense       58,000   104,000          
Natesto [Member] | License And Supply Agreement [Member]                      
Business Acquisition [Line Items]                      
Other Accrued Liabilities       $ 4,000,000   $ 4,000,000          
Natesto [Member] | First Milestone [Member] | License And Supply Agreement [Member]                      
Business Acquisition [Line Items]                      
One Time Non-Refundable Payments 2,500,000                    
Sales Revenue Target 25,000,000                    
Natesto [Member] | Second Milestone [Member] | License And Supply Agreement [Member]                      
Business Acquisition [Line Items]                      
One Time Non-Refundable Payments 5,000,000                    
Sales Revenue Target 50,000,000                    
Natesto [Member] | Third Milestone [Member] | License And Supply Agreement [Member]                      
Business Acquisition [Line Items]                      
One Time Non-Refundable Payments 7,500,000                    
Sales Revenue Target 75,000,000                    
Natesto [Member] | Forth Milestone [Member] | License And Supply Agreement [Member]                      
Business Acquisition [Line Items]                      
One Time Non-Refundable Payments 10,000,000                    
Sales Revenue Target 100,000,000                    
Natesto [Member] | Fifth Milestone [Member] | License And Supply Agreement [Member]                      
Business Acquisition [Line Items]                      
One Time Non-Refundable Payments 12,500,000                    
Sales Revenue Target 125,000,000                    
Natesto [Member] | Second Upfront [Member]                      
Business Acquisition [Line Items]                      
Business Combination, Consideration Transferred, Liabilities Incurred 2,000,000                    
Natesto [Member] | Third Upfront [Member]                      
Business Acquisition [Line Items]                      
Business Combination, Consideration Transferred, Liabilities Incurred $ 4,000,000